Orchard Therapeutics Plc ADR (ORTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORTX | AMGN | GILD | BIIB | CELG |
| Company | Orchard Therapeutics Plc ADR | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 16.65 | 265.72 | 65.50 | 201.22 | 108.01 |
| High | 16.72 | 271.68 | 66.35 | 209.89 | 108.59 |
| Low | 16.63 | 265.72 | 64.63 | 199.10 | 107.27 |
| Last | 16.70 | 270.93 | 65.77 | 209.87 | 108.24 |
| Change | +0.05 | +1.55 | +0.50 | +7.41 | +0.11 |
| % Change | +0.30% | +0.58% | +0.77% | +3.66% | +0.10% |
| Volume | 372,300 | 951,109 | 8,663,978 | 1,152,080 | 191,230,496 |
| 20-Day Average Volume | 130,995 | 2,079,262 | 6,831,438 | 1,239,575 | 16,188,930 |
| Previous Close | 16.65 | 269.38 | 65.27 | 202.46 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 16.47 | 270.03 | 68.30 | 201.15 | 108.17 |
| 20-Day Raw Stochastic | 94.20% | 43.97% | 10.94% | 75.77% | 63.25% |
| 20-Day Relative Strength | 84.63% | 46.45% | 30.09% | 50.15% | 64.69% |
| Weighted Alpha | +90.00 | +9.97 | -23.24 | -31.44 | +46.30 |
| Today's Opinion | 100% Buy | 56% Sell | 100% Sell | 80% Sell | 100% Buy |
| Previous Opinion | 100% Buy | 72% Sell | 100% Sell | 88% Sell | 100% Buy |
| Last Month's Opinion | 100% Buy | 40% Buy | 88% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.58% since 01/16/24 | +0.73% since 04/19/24 | -1.78% since 04/19/24 | +7.69% since 04/19/24 | -1.97% since 11/13/19 |
| Low | 16.39 on 01/17/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 192.75 on 04/23/24 | 107.27 on 11/20/19 |
| High | 16.72 on 01/23/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 209.64 on 04/26/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | +1.71% since 12/22/23 | -3.86% since 03/26/24 | -9.45% since 03/26/24 | -1.27% since 03/26/24 | +5.14% since 10/18/19 |
| Low | 16.38 on 01/03/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 189.44 on 04/19/24 | 102.40 on 10/21/19 |
| High | 16.72 on 01/23/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 217.57 on 03/28/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | +4.51% since 10/23/23 | -13.11% since 01/26/24 | -17.54% since 01/26/24 | -14.50% since 01/26/24 | +13.63% since 08/20/19 |
| Low | 15.78 on 10/31/23 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 189.44 on 04/19/24 | 93.41 on 08/23/19 |
| High | 16.72 on 01/23/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 251.99 on 01/31/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | +215.69% since 07/21/23 | +0.44% since 10/26/23 | -16.47% since 10/26/23 | -13.17% since 10/26/23 | +14.14% since 05/20/19 |
| Low | 4.80 on 09/11/23 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 16.72 on 01/23/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 380,109 | 144,488,960 | 81,266,176 | 29,429,788 | 77,035,920 |
| Shares Outstanding, K | 22,761 | 536,376 | 1,245,077 | 145,361 | 711,714 |
| Annual Sales | 22,660,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -150,660,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 6,300,000 | 8,196,000,000 | 7,114,000,000 | 2,386,300,000 | 4,520,000,000 |
| Last Quarter Net Income | -35,320,000 | 767,000,000 | 1,429,000,000 | 249,700,000 | 1,691,000,000 |
| 60-Month Beta | 0.55 | 0.58 | 0.19 | -0.02 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 11/13/23 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 3.67 on 04/24/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 03/04/24 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 13.47 | 10.99 |